Table 1.
Characteristic | Women (n = 507) | Men (n = 698) |
P Value |
---|---|---|---|
Region of enrollment | .06 | ||
Ziguinchor | 276 (54.4) | 419 (60.0) | |
Dakar | 231 (45.6) | 279 (40.0) | |
Age at enrollment, y, median (IQR) | 32 (26–39) | 32 (26–40) | .53 |
Age >30 y | 273 (54.1) | 390 (56.2) | .46 |
Screening reasons | <.001 | ||
Community/family testing | 73 (15.4) | 68 (10.5) | |
Antenatal care | 184 (38.8) | 0 (0.0) | |
Blood donation | 98 (20.7) | 355 (54.7) | |
Routine check-up | 119 (25.1) | 226 (34.8) | |
Alcohol consumption | 28 (5.9) | 63 (10.7) | .01 |
Family history of HCCa | 51 (19.2) | 44 (13.8) | .08 |
HBeAg positiveb | 7 (3.0) | 3 (1.0) | .08 |
ALT, IU/L, median (IQR) | 15 (10–22.45) | 19 (14–26) | <.001 |
ALT >40 IU/L | 30 (6.4) | 69 (10.3) | .02 |
HBV DNA, IU/mL, median (IQR)c | 509 (38–2906) | 648 (115–3380) | .04 |
Category | .12 | ||
<20 | 85 (20.0) | 86 (14.3) | |
20–2000 | 214 (50.4) | 320 (53.2) | |
2001–2000 | 93 (21.9) | 145 (24.1) | |
>20 000 | 33 (7.8) | 50 (8.3) | |
LSM, kPa, median (IQR) | 4.7 (4–5.6) | 5.5 (4.5–6.5) | <.001 |
Category | <.001 | ||
≤7.0 | 478 (94.3) | 579 (83.1) | |
7.1–11.0 | 24 (4.7) | 91 (13.1) | |
>11.0 | 5 (1.0) | 27 (3.9) |
Data are presented as No. (%) unless otherwise indicated. Some characteristics have different denominators because of missing data.
Abbreviations: ALT, alanine aminotransferase; HBeAg, hepatitis B envelope antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; IQR, interquartile range; LSM, liver stiffness measurement.
Data available for 584 individuals.
Data available for 540 individuals.
Data available for 1026 individuals. We excluded 1 individual without data on sex.